Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: A role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation

References

Page 1

	Year	Citations
Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. Aihao Ding, Carl Nathan, Dennis J. Stuehr The Journal of Immunology	1988	2.8K
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth Sébastien Bonnet, Stephen L. Archer, Joan Allalunis‐Turner, Cancer Cell Tumor BiologyMitophagyMitochondria-k+ Channel AxisMitochondrial FunctionInhibits Cancer Growth	2007	1.5K
The effects of extracellular pH on immune function Anne L. Lardner Journal of Leukocyte Biology Humoral ResponseImmunologyPathologyImmune SystemClinical Acidoses	2001	864
Metabolic Modulation of Glioblastoma with Dichloroacetate Evangelos D. Michelakis, Gopinath Sutendra, Peter Dromparis, Science Translational Medicine	2010	707
Antitumor activity of silver nanoparticles in Dalton&rsquo;s lymphoma ascites tumor model Sangiliyandi Gurunathan International Journal of Nanomedicine	2010	459
Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol Ming Zhou, Yuhua Zhao, Yan Ding, Molecular Cancer	2010	382
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate Shanta Dhar, Stephen J. Lippard Proceedings of the National Academy of Sciences Chemoprevention StrategyMolecular BiologyWarburg EffectChemical BiologyCancer Biology	2009	360
Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. Mikio Tomida, Yuri Yamamoto-Yamaguchi, Motoo Hozumi Journal of Biological Chemistry	1984	316
Nitric Oxide Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells by Inhibiting the Drug Efflux Chiara Riganti, Erica Miraglia, Daniele Viarisio, Cancer Research OncologyDoxorubicin ResistanceHealth SciencesOncogenic AgentNitric Oxide	2005	295
Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism Yuhua Zhao, Hao Liu, Zixing Liu, Cancer Research Trastuzumab ResistanceBreast OncologyOncologyGlycolysis InhibitorsAerobic Glycolysis	2011	285

Page 1